nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Tobramycin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Tobramycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Tobramycin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Tobramycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Tobramycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Tobramycin—Rash—Topotecan—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Tobramycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Tobramycin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Tobramycin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Tobramycin—Cough—Etoposide—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Tobramycin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Tobramycin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Tobramycin—Headache—Topotecan—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Tobramycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Tobramycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Tobramycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Tobramycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Tobramycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000569	0.000569	CcSEcCtD
Tobramycin—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Tobramycin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Tobramycin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Tobramycin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Tobramycin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.000566	CcSEcCtD
Tobramycin—Pain—Vincristine—peripheral nervous system neoplasm	0.000566	0.000566	CcSEcCtD
Tobramycin—Rash—Melphalan—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Tobramycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000563	0.000563	CcSEcCtD
Tobramycin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Tobramycin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Tobramycin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Tobramycin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Tobramycin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Tobramycin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Tobramycin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Tobramycin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Tobramycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Tobramycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Tobramycin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000541	0.000541	CcSEcCtD
Tobramycin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Tobramycin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Tobramycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Tobramycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Tobramycin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Tobramycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.00053	CcSEcCtD
Tobramycin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Tobramycin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Tobramycin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Tobramycin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Tobramycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Tobramycin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Tobramycin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Tobramycin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Tobramycin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Tobramycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Tobramycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Tobramycin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Tobramycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Tobramycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.000486	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Tobramycin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Tobramycin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Tobramycin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Tobramycin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Tobramycin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Tobramycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Tobramycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Tobramycin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Tobramycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Tobramycin—Pain—Etoposide—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Tobramycin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Tobramycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Tobramycin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Tobramycin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Tobramycin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Tobramycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Tobramycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Tobramycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Tobramycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Tobramycin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Tobramycin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Tobramycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Tobramycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Tobramycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Tobramycin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Tobramycin—Rash—Vincristine—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Tobramycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Tobramycin—Headache—Vincristine—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Tobramycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Tobramycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Tobramycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Tobramycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Tobramycin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Tobramycin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Tobramycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Tobramycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Tobramycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Tobramycin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Tobramycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Tobramycin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000356	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000355	CcSEcCtD
Tobramycin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000354	0.000354	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Tobramycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Tobramycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Tobramycin—Rash—Etoposide—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Tobramycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Tobramycin—Headache—Etoposide—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Tobramycin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000329	CcSEcCtD
Tobramycin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Tobramycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Tobramycin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Tobramycin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Tobramycin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000213	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000206	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000205	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000199	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000199	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000197	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Tobramycin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Tobramycin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000184	CcSEcCtD
Tobramycin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000178	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000177	CcSEcCtD
Tobramycin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Tobramycin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000174	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000165	CcSEcCtD
